Clinical trial
Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic…
NCT00448552 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00448552 |
|---|---|
| Title | Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer |
| Official title | Treatment of Relapsed or Metastatic Head and Neck Carcinomas With Oxaliplatin and Capecitabine |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | capecitabine, oxaliplatin |
| Enrollment | 30 |
| Start date | Feb 1, 2004 |
| Primary completion | Apr 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Mar 19, 2007 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: